J. B. Chemicals & Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has J. B. Chemicals & Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $39,941,271,000 last year, which is more than in the previous period. 27% of J. B. Chemicals & Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $10,707,978,000, which means an increase by 128% compared compared to last year.
Debt to Assets
| 2011 | 9993796000 | 3.07B | 30.8% |
|---|---|---|---|
| 2012 | 11977989000 | 2.27B | 19.02% |
| 2015 | 14872470000 | 4.92B | 33.11% |
| 2016 | 15573841000 | 4.62B | 29.67% |
| 2018 | 17648899000 | 3.20B | 18.16% |
| 2019 | 17910005000 | 3.08B | 17.2% |
| 2020 | 18135611000 | 3.75B | 20.71% |
| 2021 | 22381152000 | 4.24B | 18.98% |
| 2022 | 26074022000 | 4.68B | 17.98% |
| 2024 | 39941271000 | 10.70B | 26.81% |
JBCHEPHARM.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 882.15M | 565.44M | 286.85M | 290.07M | 353.96M | 279.42M | 119.99M | 164.08M | 2.19B | 1.26B |
Short term investments | 3.71B | 1.06M | 6.64B | 3.33B | 3.60B | 3.83B | 1.95B | 5.55B | 2.98B | 681.14M |
Net receivables | 7.04B | 6.23B | 4.18B | 3.61B | 4.06B | 3.07B | 2.75B | 2.63B | 0 | 0 |
Inventory | 5.02B | 4.09B | 3.47B | 2.74B | 2.43B | 2.13B | 1.87B | 1.50B | 1.01B | 1.11B |
Other current assets | 1.86B | 1.84B | 928.22M | 4.35B | 29.34M | 991.90M | 5.11B | 3.60B | 2.46B | 3.45B |
Total current assets | 18.53B | 12.74B | 15.52B | 10.72B | 10.49B | 10.46B | 7.77B | 10.83B | 8.66B | 6.52B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 6.34B | 5.66B | 5.69B | 5.84B | 5.59B | 5.81B | 5.01B | 3.59B | 2.79B | 2.44B |
Goodwill | 574.59M | 574.59M | 574.59M | 531.4M | 531.4M | 531.4M | 531.4M | 169.02M | 0 | 169.02M |
Intangible assets | 13.88B | 6.71B | 321.05M | 300.92M | 233.77M | 226.52M | 162.32M | 77.75M | 360.42M | 4.68M |
Long term investments | 237.08M | 127.22M | 129.08M | 694.54M | 958.75M | -3.33B | -104.18M | -5.46B | -2.95B | 168.67M |
Other non-current assets | 362.77M | 177.24M | 64.41M | 1K | -107.85M | 3.57B | 1K | 5.91B | 3.12B | 682.31M |
Total non-current assets | 21.40B | 13.32B | 6.85B | 7.40B | 7.41B | 7.17B | 7.79B | 4.04B | 3.31B | 3.47B |
Total assets | 39.94B | 26.07B | 22.38B | 18.13B | 17.91B | 17.64B | 15.57B | 14.87B | 11.97B | 9.99B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 129.85M | 1.16B | 1.08B | 1.50B | 1.33B | 1.35B | 1.29B | 2.55B | 0 | 0 |
Short term debt | 3.44B | 339.41M | 398.46M | 369.89M | 257.97M | 292.92M | 1.93B | 1.27B | 552.26M | 0 |
Total current liabilities | 8.68B | 3.83B | 3.45B | 3.12B | 2.43B | 2.74B | 4.35B | 4.59B | 1.88B | 1.22B |
| Non-current liabilities: | ||||||||||
Long term debt | 332.77M | 206.17M | 51.41M | 12.29M | 35.26M | 0 | 0 | 4M | 125.45M | 1.69B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 144.02M |
Other non-current liabilities | 183.88M | 137.30M | 125.71M | 73.86M | 22.02M | 36.00M | 104.33M | 205.97M | 82.68M | 18.66M |
Total non-current liabilities | 2.02B | 850.73M | 794.11M | 627.24M | 648.39M | 456.59M | 262.57M | 326.23M | 395.23M | 1.85B |
Total liabilities | 10.70B | 4.68B | 4.24B | 3.75B | 3.08B | 3.20B | 4.62B | 4.92B | 2.27B | 3.07B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |